Todd C. Davis - Jun 14, 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Todd Davis
Stock symbol
CHRO
Transactions as of
Jun 14, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 08:00 PM
Previous filing
Mar 27, 2024
Next filing
Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Restricted Stock Units Award +129K +152.23% 214K Jun 14, 2024 Common Stock 129K $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2024, the Reporting Person was granted restricted stock units to purchase 128,977 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.